Effects of chemical inhibition of N-WASP, a critical regulator of actin polymerization on aqueous humor outflow through the conventional pathway.
The integrity of actin cytoskeletal organization in aqueous humor outflow pathway is thought to play a critical role in modulation of aqueous humor outflow through the trabecular meshwork. Our understanding of the regulation of actin cytoskeletal dynamics in outflow pathway, however, is very limited. To explore the potential importance of Neural Wiskott-Aldrich syndrome protein (N-WASP), a critical regulator of actin polymerization/nucleation in aqueous humor outflow pathway, the effects of Wiskostatin, a selective pharmacological inhibitor of N-WASP, on aqueous humor outflow facility were evaluated using enucleated porcine eyes and a constant pressure perfusion system. Further, drug induced effects on actin cytoskeletal organization, cell adhesions, myosin II phosphorylation, matrix metalloproteinase (MMP) activity, and cytoskeletal protein profile in porcine trabecular meshwork (TM) cells were determined by immunofluorescence, zymography, and mass spectrometry. Aqueous humor outflow facility was increased significantly and progressively in the Wiskostatin perfused porcine eyes. The Wiskostatin perfused eyes appear to exhibit increased giant vacuoles in the inner wall of aqueous plexi and deformation of aqueous plexi. The Wiskostatin treated TM cells demonstrated extensive vacuoles in their cytosol, and both actin stress fibers and focal adhesions were decreased in a reversible manner. The drug-treated TM cells also revealed decreased myosin II and actin in the cytoskeletal enriched triton insoluble fraction but did not affect myosin II phosphorylation or MMP-2 activity. These data demonstrate that the chemical inhibition of N-WASP increases aqueous humor outflow facility in association with decreased actomyosin interaction and cell adhesive interactions revealing the importance of N-WASP in homeostasis of aqueous humor outflow.
Inoue
Toshihiro
T
Department of Ophthalmology, Duke University School of Medicine, Durham, NC 27710, USA.
Pattabiraman
Padmanabhan P
PP
Epstein
David L
DL
Vasantha Rao
P
P
D000199:Actins / Q000378:metabolism*; D000818:Animals; D001082:Aqueous Humor / Q000378:metabolism*; D002227:Carbazoles / Q000494:pharmacology*; D002478:Cells, Cultured; D019084:Fluorescent Antibody Technique, Indirect; D022001:Focal Adhesions / Q000378:metabolism; D024462:Myosin Type II / Q000378:metabolism; D010766:Phosphorylation; D011412:Propanolamines / Q000494:pharmacology*; D019032:Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; D022502:Stress Fibers / Q000378:metabolism; D013552:Swine; D053719:Tandem Mass Spectrometry; D014129:Trabecular Meshwork / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D014617:Vacuoles / Q000473:pathology; D051317:Wiskott-Aldrich Syndrome Protein, Neuronal / Q000037:antagonists & inhibitors*
D000199:Actins; D002227:Carbazoles; D011412:Propanolamines; D051317:Wiskott-Aldrich Syndrome Protein, Neuronal; C489942:wiskostatin; D024462:Myosin Type II